Radioresponse and prognosis of malignant glioma.

Radioresponse and prognosis of 91 malignant gliomas were studied to examine the efficacy of radiotherapy. There was no case of complete response. No statistically significant difference was observed among the prognoses of patients with various radiation methods. General survival rate was significantly higher than relapse-free survival rate both in astrocytoma grade III and in glioblastoma. This means that the retreatment after relapse is exceedingly important in any malignant glioma. In comparison with reported resection alone data, the efficiency of radiotherapy was evident in astrocytoma grade III and a part of glioblastoma; cases with minimal or no contrast enhanced area (CEA) in CT scans prior to irradiation. Poor radioresponders of glioblastoma with CEA should be reoperated.

[1]  K. Trott,et al.  Survival and quality of life after continuous accelerated radiotherapy of glioblastomas. , 1987, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[2]  E. Alexander,et al.  Evaluation of BCNU and/or radiotherapy in the treatment of anaplastic gliomas. A cooperative clinical trial. , 1978, Journal of neurosurgery.

[3]  H. Blattmann,et al.  Anaplastic astrocytoma and glioblastoma: pion irradiation with the dynamic conformation technique at the Swiss Institute for Nuclear Research (SIN). , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[4]  J. Ransohoff.  Radiation therapy for brain tumors , 1991, Annals of neurology.

[5]  E. Alexander,et al.  Results of a randomized trial comparing BCNU plus radiotherapy, streptozotocin plus radiotherapy, BCNU plus hyperfractionated radiotherapy, and BCNU following misonidazole plus radiotherapy in the postoperative treatment of malignant glioma. , 1989, International journal of radiation oncology, biology, physics.

[6]  H. Bloom,et al.  Fast neutrons compared with megavoltage x-rays in the treatment of patients with supratentorial glioblastoma: a controlled pilot study. , 1980, International journal of radiation oncology, biology, physics.

[7]  H. Koprowski,et al.  Malignant astrocytomas treated with iodine-125 labeled monoclonal antibody 425 against epidermal growth factor receptor: a phase II trial. , 1992, International journal of radiation oncology, biology, physics.

[8]  K. Wallner,et al.  Patterns of failure following treatment for glioblastoma multiforme and anaplastic astrocytoma. , 1989, International journal of radiation oncology, biology, physics.

[9]  L. Skarsgard,et al.  Pion therapy at TRIUMF. Treatment results for astrocytoma grades 3 and 4: a pilot study. , 1990, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[10]  D. Schoenfeld,et al.  Comparison of postoperative radiotherapy and combined postoperative radiotherapy and chemotherapy in the multidisciplinary management of malignant gliomas . A joint radiation therapy oncology group and eastern cooperative oncology group study , 1983, Cancer.

[11]  G. Sheline.  Radiation therapy of brain tumors , 1977, Cancer.

[12]  R. Katakura,et al.  [Enhancement of the effect of X-irradiation against cultured human glioblastoma cells by pretreatment with ACNU]. , 1989, Neurologia medico-chirurgica.

[13]  Y. Takai,et al.  Low‐dose rate telecobalt therapy as a boost against esophageal carcinomas , 1991, Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica.

[14]  G. Laramore,et al.  Radiation Therapy Oncology Group (RTOG) survival data on anaplastic astrocytomas of the brain: does a more aggressive form of treatment adversely impact survival? , 1989, International journal of radiation oncology, biology, physics.

[15]  A. Hercbergs,et al.  Hypofractionated radiation therapy and concurrent cisplatin in malignant cerebral gliomas. Rapid palliation in low performance status patients , 1989, Cancer.

[16]  D. Nelson,et al.  A randomized comparison of misonidazole sensitized radiotherapy plus BCNU and radiotherapy plus BCNU for treatment of malignant glioma after surgery: final report of an RTOG study. , 1983, International journal of radiation oncology, biology, physics.